BIOMERICA INC Form DEFR14A: Revised definitive proxy materials
Filings on SEC EDGAR, newest first; amendments sit with their base form. Values are as filed.
- 2003-07-10: Form DEFR14A; Description Revised definitive proxy materials; Document biomerica_defr14a-070903.txt.
- 2003-07-01: Form DEFR14A; Description Revised definitive proxy materials; Document biomerica_defr14a-2002.txt.
- 1999-09-27: Form DEFR14A; Description BIOMERICA DEFINITIVE PROXY.
| Filed | Form | Period of report | Description | Document |
|---|---|---|---|---|
| 2003-07-10 | DEFR14A | Revised definitive proxy materials | biomerica_defr14a-070903.txt | |
| 2003-07-01 | DEFR14A | Revised definitive proxy materials | biomerica_defr14a-2002.txt | |
| 1999-09-27 | DEFR14A | BIOMERICA DEFINITIVE PROXY |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Q/C TECHNOLOGIES, INC. (QCLS) | United States | $0.008B | -1.93 |
| Cardio Diagnostics Holdings, Inc. (CDIO) | United States | $0.006B | |
| VOLITIONRX LTD (VNRX) | $0.003B | -0.64 | |
| IMMUCELL CORP /DE/ (ICCC) | United States | $0.091B | 116.10 |
| Insight Molecular Diagnostics Inc. (IMDX) | United States | $0.129B | -3.90 |
| MYRIAD GENETICS INC (MYGN) | United States | $0.397B | -4.84 |
| Alpha Teknova, Inc. (TKNO) | United States | $0.500B | -18.12 |
| QuidelOrtho Corp (QDEL) | United States | $0.733B | -0.90 |
| ACHIEVE LIFE SCIENCES, INC. (ACHV) | United States | $0.806B | -5.88 |
| Intellia Therapeutics, Inc. (NTLA) | United States | $1.705B | -5.92 |